TENX — Tenax Therapeutics Share News
0.000.00%
Last trade - 00:00Brief: Tenax Therapeutics Q3 Net Income USD -15.804 Million
Brief: Tenax Therapeutics Announces European Patent Office Intention To Grant Patent Covering Use Of Levosimendan In Ph-Hfpef
Brief: Tenax Therapeutics Inc - Co And Orion Amend License Agreement - SEC Filing
Tenax Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Tenax Therapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview
Tenax Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Tenax Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview
Tenax Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary
Tenax Therapeutics Inc expected to post a loss of 42 cents a share - Earnings Preview
Brief: Tenax Therapeutics Announces $25 Million Private Placement
Tenax Therapeutics Inc reports results for the quarter - Earnings Summary
Brief: Tenax Therapeutics Reports Q3 2024 Financial Results And Provides A Corporate Update
Tenax Therapeutics Inc expected to post a loss of $1.39 a share - Earnings Preview
Brief: T. Rowe Price Associates, Inc Reports Passive Stake Of 19.99% In Tenax Therapeutics Inc As Of August 31, 2024- SEC Filing
Brief: Stonepine Capital Management Reports 9.99% Passive Stake In Tenax Therapeutics
Tenax Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Tenax Therapeutics Inc expected to post a loss of $1.98 a share - Earnings Preview
Tenax Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Tenax Therapeutics Inc expected to post a loss of $2.40 a share - Earnings Preview